Bonk, Inc. (NASDAQ:BNKK) Short Interest Down 36.6% in July

Bonk, Inc. (NASDAQ:BNKK) saw a large decrease in short interest in July. As of July 31st, there was short interest totaling 193,599 shares, a decrease of 36.6% from the July 15th total of 305,481 shares. Based on an average daily trading volume, of 58,461 shares, the days-to-cover ratio is presently 3.3 days. Currently, 5.0% of the company’s stock are short sold.

Institutional Trading of Bonk

Several large investors have recently added to or reduced their stakes in the business. State Street Corp acquired a new position in shares of Bonk during the 4th quarter worth $33,000. Steward Partners Investment Advisory LLC acquired a new stake in shares of Bonk in the 4th quarter valued at $37,000. BlackRock Inc. acquired a new stake in shares of Bonk in the 2nd quarter valued at $50,000. Jane Street Group LLC acquired a new stake in shares of Bonk in the 4th quarter valued at $96,000. Finally, Geode Capital Management LLC bought a new stake in Bonk in the fourth quarter worth $128,000. 12.55% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of Bonk in a research note on Friday, July 24th. Wall Street Zen upgraded Bonk from a “sell” rating to a “hold” rating in a report on Saturday, July 4th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Bonk has a consensus rating of “Sell”.

Bonk Stock Performance

Shares of Bonk stock traded down $0.03 during trading on Tuesday, hitting $0.94. 130,863 shares of the stock traded hands, compared to its average volume of 699,401. The stock has a market cap of $7.53 million, a P/E ratio of -0.25 and a beta of 1.99. The company has a fifty day moving average price of $1.26 and a two-hundred day moving average price of $2.29. Bonk has a twelve month low of $0.91 and a twelve month high of $21.20.

Bonk (NASDAQ:BNKK) last released its quarterly earnings data on Friday, August 14th. The company reported ($0.76) EPS for the quarter. The firm had revenue of $1.16 million during the quarter. Bonk had a negative return on equity of 122.84% and a negative net margin of 952.21%.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.